000 | 01650 a2200457 4500 | ||
---|---|---|---|
005 | 20250515232915.0 | ||
264 | 0 | _c20101012 | |
008 | 201010s 0 0 eng d | ||
022 | _a1471-2369 | ||
024 | 7 |
_a10.1186/1471-2369-11-15 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrideau, Gaƫlle | |
245 | 0 | 0 |
_aOver-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistance. _h[electronic resource] |
260 |
_bBMC nephrology _cJul 2010 |
||
300 |
_a15 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenosine Deaminase _xbiosynthesis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 |
_aEdema _xetiology |
650 | 0 | 4 | _aEnzyme Induction |
650 | 0 | 4 | _aGenes, Synthetic |
650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xgenetics |
650 | 0 | 4 |
_aKidney Glomerulus _xenzymology |
650 | 0 | 4 |
_aMembrane Proteins _xbiosynthesis |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aNatriuresis _xdrug effects |
650 | 0 | 4 |
_aNephrotic Syndrome _xchemically induced |
650 | 0 | 4 |
_aPodocytes _xdrug effects |
650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
650 | 0 | 4 |
_aProteinuria _xdrug therapy |
650 | 0 | 4 |
_aPuromycin Aminonucleoside _xpharmacology |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xbiosynthesis |
650 | 0 | 4 | _aSpecies Specificity |
700 | 1 | _aDoucet, Alain | |
773 | 0 |
_tBMC nephrology _gvol. 11 _gp. 15 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2369-11-15 _zAvailable from publisher's website |
999 |
_c19990719 _d19990719 |